Juvederm clinical trials are research studies where people volunteer to receive Juvederm injections under controlled medical conditions. These trials test how the product works, its safety profile, and how long the results last. Unlike buying Juvederm at a dermatologist's office, clinical trials involve structured protocols where doctors monitor participants over weeks or months, collecting detailed data about what happens.
Learn About Paying Your FGUA Bill Online →
The basic structure works like this: researchers recruit participants who meet certain health characteristics, divide them into groups, administer the treatment according to a strict protocol, and then observe and measure results at scheduled intervals. Some trials may include a control group that receives a placebo injection or a different filler product to compare outcomes.
Clinical trials for Juvederm have been running since the 1990s and continue today. The FDA approved Juvederm in 2006 based on clinical trial data, but companies still conduct ongoing trials to test new formulations, different injection techniques, or applications in new facial areas. These newer trials explore products like Juvederm Voluma (for cheek volume), Juvederm Vollure (designed to last longer), and Juvederm Volbella (for subtle lip enhancement).
Researchers measure results using standardized methods. The Wrinkle Severity Rating Scale is one common tool—doctors assess wrinkle depth before treatment and at multiple points afterward, often using photographs to track visible changes. Participants also report their own observations about satisfaction and any side effects they notice.
Takeaway: Clinical trials represent a structured research environment where medical professionals closely monitor Juvederm treatment rather than a typical cosmetic procedure experience. Understanding this framework helps explain why trials differ from standard office visits.
Allergan, the company behind Juvederm, conducts clinical trials for multiple reasons beyond the initial FDA approval. They test new product variations, longer-lasting formulations, and applications in different facial zones. The company also performs safety monitoring trials, especially since Juvederm injections carry known risks like bruising, swelling, and rare but serious complications such as vascular occlusion (blocked blood vessels).
Free Guide to Pay by Plate Illinois Billing →
Recent trial focuses have included comparing Juvederm's results against competing products like Restylane and Radiesse. These head-to-head studies help clinicians understand which fillers work better for specific wrinkle types or facial areas. Some trials specifically examine how results vary based on age, skin type, or the depth of wrinkles being treated.
A significant area of ongoing research involves product longevity. Original Juvederm formulations lasted about six months. Newer versions like Juvederm Voluma were designed to last up to two years in the cheeks. Trials testing these products measure how long visible improvements actually persist and when participants need retreatment.
Researchers also investigate optimal injection techniques. Different depths, volumes, and placement strategies produce different results. Some trials compare threading techniques (placing filler along a line) versus bolus techniques (placing small deposits at specific points) to see which approach creates more natural-looking outcomes.
Safety data collection represents another crucial trial function. Researchers document all adverse events—from minor bruising lasting a few days to serious complications requiring medical intervention. This ongoing monitoring helps identify patterns and informs safety communications to doctors and patients.
Takeaway: Trials aren't just about proving Juvederm works; they generate specific data about duration, technique optimization, safety profiles, and how results compare to alternatives—information that guides clinical practice.
Trial participants vary widely, but researchers typically recruit adults aged 18 to 65 with moderate to severe facial wrinkles, usually in nasolabial folds (lines from nose to mouth corner) or marionette lines (from mouth corner downward). Some trials recruit only women; others include men. Age ranges, wrinkle severity, and skin type all factor into who researchers are looking for in specific studies.
Free Guide to Mold Removal Methods for Walls →
Participation requirements usually include being in generally good health, not being pregnant or nursing, and having realistic expectations about results. Researchers typically exclude people taking blood thinners, those with certain skin conditions, or individuals with a history of allergic reactions to hyaluronic acid (the main ingredient in Juvederm).
What does participation actually look like? A typical trial might involve 4 to 6 visits spread over several months. The first visit includes screening questions, photos, and measurements of existing wrinkles. The second visit involves the actual injections, which feel similar to regular cosmetic filler treatment—most people describe a brief sharp sensation followed by minor pressure. The procedure takes 15 to 30 minutes.
Follow-up visits occur at scheduled intervals: often one week after injection, then at 2 weeks, 4 weeks, 3 months, and 6 months. At each visit, researchers take photographs, measure wrinkles using standardized scales, and ask about satisfaction and any side effects. Participants complete questionnaires about their experience and how they feel about their appearance.
Most trial participants experience common side effects similar to regular Juvederm treatment: bruising, swelling, redness, and tenderness at injection sites. These typically resolve within a few days. Serious side effects are rare but can include granulomas (small nodules under the skin) or vascular complications. Trial participants receive detailed information about what to watch for and how to contact researchers if concerning symptoms develop.
Takeaway: Trial participation requires several visits over months and involves standard assessment procedures, but the actual treatment experience resembles conventional filler injections with similar temporary side effects for most people.
ClinicalTrials.gov, maintained by the National Library of Medicine, is the primary registry where Juvederm trials are listed. Searching "Juvederm" on this site reveals current and recent trials, including location, contact information, and basic description of what researchers are studying. The site includes filters for location (state or country), age range, and trial status (recruiting, ongoing, closed).
How to Delete Your Fitbit Account Guide →
The listing for each trial includes important details: the trial's official title, the research organization conducting it, inclusion and exclusion criteria, and a brief description of what the study measures. Many listings include a link to contact information and instructions for how to reach the research site if you want more information.
Dermatology research centers and university hospitals often conduct Juvederm trials. Large academic medical centers frequently appear as trial sites because they have the infrastructure and expertise to conduct FDA-regulated research. Some private dermatology clinics also participate in sponsored trials.
Industry sources matter too. Allergan's official website and physician-focused publications sometimes list recruiting trials. However, ClinicalTrials.gov remains the most comprehensive and independent source, as trials must be registered there to be conducted legally in the United States.
When searching for trial information, note that trial status matters. "Recruiting" means the study is actively seeking participants. "Active, not recruiting" means the study is ongoing but has already enrolled all needed participants. "Completed" means the trial finished and results may be published in medical journals. Understanding these statuses prevents contacting sites that cannot accept new participants.
Takeaway: ClinicalTrials.gov is the reliable starting point for learning about specific Juvederm studies, their location, contact methods, and current enrollment status—avoiding the need to navigate commercial websites or outdated information.
Once a trial concludes, researchers analyze the data and publish findings in peer-reviewed medical journals. These publications represent the scientific record of how Juvederm performed in the controlled study environment. Results typically appear in dermatology journals like the Journal of Cosmetic Dermatology, Dermatologic Surgery, or Aesthetic Surgery Journal.
Learn How to Grow Sweet Corn at Home →
Published results typically include before-and-after photographs showing wrinkle improvement, numerical data about how many participants achieved certain levels of improvement (like 50% wrinkle reduction), duration of results, and detailed safety information including frequency and type of adverse events. Researchers present not just average results but also breakdowns by age, gender, or other participant characteristics to show how outcomes varied.
A landmark 2002 trial published in Dermatologic Surgery showed that 82% of
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.